Generalized Anxiety Disorder (GAD)
General Anxiety Disorder is a common mental health condition characterized by excessive and persistent worry, tension, and nervousness that is difficult to control. If you or someone you know is struggling with generalized anxiety disorder, this study may be of interest. You may eligible to participate if you:
Are an adult between the ages 18-65 years old with Generalized Anxiety Disorder (GAD).
Currently taking paroxetine, escitalopram, duloxetine, or venlafaxine ER for at least 8 weeks.
Are not currently experiencing a depressive episode.
Have no lifetime history of schizophrenia, schizoaffective disorder, bipolar I or II disorder, posttraumatic stress disorder, or developmental/cognitive disorders
Additional criteria may apply. Please contact the study team to confirm eligibility. We provide compensation for your time and transportation.
Your health is important to us.
This study is designed to evaluate the efficacy of a drug for the treatment of generalized anxiety disorder (GAD) in adults.
Our dedicated team of specialists is committed to your safety and well-being, providing personalized attention and support throughout the trial. Join us in this vital endeavor and be a part of a meaningful change in mental health treatment.
Help us learn more about the treatment of generalized anxiety disorder (GAD).
Watching a loved one struggle with generalized anxiety disorder is hard. Help them discover new treatment options.
